JP2004535436A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535436A5
JP2004535436A5 JP2003507080A JP2003507080A JP2004535436A5 JP 2004535436 A5 JP2004535436 A5 JP 2004535436A5 JP 2003507080 A JP2003507080 A JP 2003507080A JP 2003507080 A JP2003507080 A JP 2003507080A JP 2004535436 A5 JP2004535436 A5 JP 2004535436A5
Authority
JP
Japan
Prior art keywords
trioxolane
substituted
spiro
dispiro
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003507080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535436A (ja
JP4303585B2 (ja
Filing date
Publication date
Priority claimed from US09/886,666 external-priority patent/US6486199B1/en
Application filed filed Critical
Publication of JP2004535436A publication Critical patent/JP2004535436A/ja
Publication of JP2004535436A5 publication Critical patent/JP2004535436A5/ja
Application granted granted Critical
Publication of JP4303585B2 publication Critical patent/JP4303585B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003507080A 2001-06-21 2002-06-21 1,2,4−トリオキソラン抗マラリア物質 Expired - Fee Related JP4303585B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/886,666 US6486199B1 (en) 2001-06-21 2001-06-21 Spiro and dispiro 1,2,4-trioxolane antimalarials
PCT/US2002/019767 WO2003000676A1 (en) 2001-06-21 2002-06-21 1,2,4-trioxolane antimalarials

Publications (3)

Publication Number Publication Date
JP2004535436A JP2004535436A (ja) 2004-11-25
JP2004535436A5 true JP2004535436A5 (enExample) 2005-09-29
JP4303585B2 JP4303585B2 (ja) 2009-07-29

Family

ID=25389491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003507080A Expired - Fee Related JP4303585B2 (ja) 2001-06-21 2002-06-21 1,2,4−トリオキソラン抗マラリア物質

Country Status (24)

Country Link
US (1) US6486199B1 (enExample)
EP (1) EP1414813B1 (enExample)
JP (1) JP4303585B2 (enExample)
KR (1) KR100759144B1 (enExample)
CN (1) CN1545508B (enExample)
AT (1) ATE339411T1 (enExample)
AU (1) AU2002327183B2 (enExample)
BR (1) BRPI0210549B8 (enExample)
CA (1) CA2451006C (enExample)
CY (1) CY1106214T1 (enExample)
DE (1) DE60214733T8 (enExample)
DK (1) DK1414813T3 (enExample)
ES (1) ES2271323T3 (enExample)
HU (1) HUP0400246A3 (enExample)
IL (1) IL159474A0 (enExample)
MX (1) MXPA03011915A (enExample)
NO (1) NO20035721L (enExample)
PL (1) PL226418B1 (enExample)
PT (1) PT1414813E (enExample)
RU (1) RU2271357C2 (enExample)
SI (1) SI1414813T1 (enExample)
UA (1) UA78709C2 (enExample)
WO (1) WO2003000676A1 (enExample)
YU (1) YU100703A (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536887T1 (de) * 2002-06-06 2011-12-15 Univ Washington Kovalente konjugate zwischen mit artemisinin verwandten endoperoxiden und eisentragenden proteinen und anwendungsverfahren
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
FR2862304A1 (fr) 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
WO2006010362A1 (de) * 2004-07-23 2006-02-02 Justus-Liebig-Universität Giessen Aminoadamantan-derivate, verfahren zu ihrer herstellung und ihre verwendung
US20060040761A1 (en) * 2004-08-23 2006-02-23 Sam-Kyu Shin Scale mark mat for putting practice
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
US20090042821A1 (en) 2005-05-18 2009-02-12 Arno Appavoo Enose Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
WO2007036947A1 (en) * 2005-09-30 2007-04-05 Ipca Laboratories Limited Delayed release anti-malarial composition
EP1934194B1 (en) 2005-10-04 2010-04-14 The Director General, Defence Research & Development Organisation Anti-malarial compound isolated from gomphostemma niveum
US20070231300A1 (en) * 2006-03-28 2007-10-04 Washington, University Of Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
EP2007723A2 (en) 2006-04-11 2008-12-31 Novartis AG Organic compounds
AP2525A (en) * 2006-05-17 2012-12-05 Ranbaxy Lab Ltd Antimarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
WO2007138435A2 (en) * 2006-05-24 2007-12-06 Ranbaxy Laboratories Limited A process for the preparation of dispiro 1,2,4-trioxolane antimalarials (oz277)
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
GB0619333D0 (en) * 2006-09-30 2006-11-08 Univ Liverpool Dispiro tetraoxane compounds
WO2008046109A2 (en) * 2006-10-13 2008-04-17 University Of Washington Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
JP5587776B2 (ja) 2008-07-01 2014-09-10 国立大学法人 岡山大学 新規抗住血吸虫剤
WO2010011684A2 (en) 2008-07-21 2010-01-28 The Regents Of The University Of California Prodrug and fluoregenic compositions and methods for using the same
JP2014522856A (ja) 2011-07-14 2014-09-08 ランバクシー ラボラトリーズ リミテッド アルテロランおよびピペラキンの安定した投与形態物
WO2015123595A1 (en) 2014-02-14 2015-08-20 The Regents Of The University Of California Cyclic peroxides as prodrugs for selective delivery of agents
AU2015370911B2 (en) 2014-12-23 2020-07-09 Bergenbio Asa Inhibitors of Akt kinase
RU2601315C1 (ru) * 2015-06-10 2016-11-10 Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук Способ получения пентаоксаспироалканов
WO2019005977A1 (en) * 2017-06-27 2019-01-03 The Regents Of The University Of California Trioxolane agents
CN108424371B (zh) * 2018-01-19 2021-07-16 北京理工大学 2-(4-氨基环己基)-乙酸乙酯的制备方法
US20210386814A1 (en) * 2020-05-20 2021-12-16 Amanuel Tesfazion Methods and compound for the treatment of malaria
JP7630193B2 (ja) * 2021-02-01 2025-02-17 西湖大学 1,2,4,5-テトラオキサン化合物の標的化送達及びその使用
CN117085004A (zh) * 2023-09-27 2023-11-21 赣南师范大学 一种2,6-二苯亚甲基环己酮类似物在制备抗血吸虫药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621062A (en) 1966-10-25 1971-11-16 Sterling Drug Inc 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol
US3673222A (en) 1969-11-26 1972-06-27 Sydney Archer 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof
US3682991A (en) 1970-10-19 1972-08-08 Sterling Drug Inc 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids
SU1421743A1 (ru) * 1987-02-18 1988-09-07 Физико-химический институт им.А.В.Богатского Способ получени 11-нитро-12- @ (2-метокси)-этокси @ -бензо-9-краун-3
US4916204A (en) 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4816478A (en) 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
US5053342A (en) 1987-12-24 1991-10-01 Litmus Concepts, Inc. Fecal occult blood test reagents
US5559145A (en) 1988-06-01 1996-09-24 Oxaco S.A. 1,2,4-trioxane derivatives
US5270344A (en) 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
JP2867529B2 (ja) 1990-01-22 1999-03-08 三菱電機株式会社 投写型表示装置
US5216175A (en) 1990-03-23 1993-06-01 Sri International Antimalarial analogs of artemisinin
US5219880A (en) 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
DE4125201C1 (enExample) * 1991-07-30 1992-10-01 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
US5510356A (en) 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
US5171676A (en) 1991-10-31 1992-12-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of introducing hydroxyl groups into artemisinin and its derivatives
US5430148A (en) 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
BR9306816A (pt) 1992-07-28 1998-12-08 Procter & Gamble Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado
US5721209A (en) 1995-02-03 1998-02-24 The Regents Of The University Of California Iron chelator and inhibitor of iron-mediated oxidant injury
US5780675A (en) 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
US5578637A (en) 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5672624A (en) 1995-11-22 1997-09-30 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5817692A (en) 1995-11-22 1998-10-06 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5932591A (en) 1996-12-02 1999-08-03 Johns Hopkins University C3 substituted trioxanes useful as antiparasitic drugs

Similar Documents

Publication Publication Date Title
JP2004535436A5 (enExample)
RU2221782C2 (ru) Замещенные циклические аминовые ингибиторы металлопротеаз
JP2002030084A5 (enExample)
CA2451006A1 (en) 1,2,4-trioxolane antimalarials
RU2007101685A (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
RU2006131132A (ru) 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью
TW200607807A (en) Macrocyclic beta-secretase inhibitors
RU2006137706A (ru) 9-замещенное производное 8-оксоаденина
JP2006500394A5 (enExample)
RU2013108641A (ru) Способ лечения офтальмологических заболеваний с использованием соединений ингибиторов киназы в пролекарственных формах
JP2006509749A5 (enExample)
RU95117068A (ru) Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений
RU2008126245A (ru) Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции
RU2009136996A (ru) Трициклические соединения, которые можно использовать для лечения нарушений, связанных с анормальным уровнем содержания железа в организме
JP2005506298A5 (enExample)
EP1782804A4 (en) MEDICAL COMPOSITION AS IMMUNOSUPPRESSIVUM
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
RU2007108415A (ru) Новое циклическое производное аминобензойной кислоты
JP2000169371A5 (enExample)
RU2222532C2 (ru) Соединения ряда бензофуроксана, способ их получения (варианты), фармацевтическая композиция, способ получения парентерального состава и способ лечения коронарных сердечных заболеваний
RU2006122935A (ru) Новые производные бензимидазола и имидазопиридина и их применение в качестве лекарственных средств
RU2313524C2 (ru) МИТИЛИНДОЛЫ И МЕТИЛПИРРОЛОПИРИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ α-1-АДРЕНЕРГИЧЕСКИХ АГОНИСТОВ
CA2373395A1 (en) Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
JP2017516824A5 (enExample)
KR880001593A (ko) 4-(아로일아미노)피페리딘부탄아미드 유도체